Jim Cramer: This Health Care Stock Is Pure Spec, The Only Neocloud I Like Is

On CNBC’s “Mad Money Lightning Round,” Jim Cramer said Nuvation Bio Inc. (NYSE: NUVB) is a “pure spec.” Nuvation Bio, on Aug. 20, was granted the FDA Fast Track Designation for safusidenib for the treatment of IDH1-mutant glioma.

When asked about IREN Limited (NASDAQ: IREN), Cramer said, “If you’re going to do neoclouds, the only one I like is CoreWeave (NASDAQ: CRWV).”

On Sept. 2, BTIG analyst Gregory Lewis reiterated a Buy rating on IREN and maintained a price target of $80.

Cramer said he doesn’t know about Seneca Foods Corporation (NASDAQ: SENEA). On the earnings front, Seneca Foods posted mixed results for the first quarter on Aug. 6.

“I think people recognize it is a lot harder to build a nuclear power plant,” Cramer said when asked about NuScale Power Corporation (NYSE: SMR).